Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

US FDA declines approval of Eli Lilly and Incyte’s baricitinib drug to treat RA

pharmaceutical-technologyApril 19, 2017

Tag: Drug , FDA

PharmaSources Customer Service